Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 8:17:e05.
doi: 10.15420/icr.2021.11. eCollection 2022 Jan.

A Review of the Impella Devices

Rami Zein  1 , Chirdeep Patel  1 , Adrian Mercado-Alamo  1 , Theodore Schreiber  1 , Amir Kaki  1
Affiliations
Review

A Review of the Impella Devices

Rami Zein et al. Interv Cardiol. .

Abstract

The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogenic shock or to support high-risk percutaneous coronary intervention (HRPCI) has grown over the past decade. There is currently no consensus on best practice regarding its use in these two distinct indications. Impella heart pumps (Abiomed) are intravascular microaxial blood pumps that provide temporary MCS during HRPCI or in the treatment of cardiogenic shock. The authors outline technical specifications of the individual Impella heart pumps and their accompanying technology, the Automated Impella Controller and SmartAssist, their indications for use and patient selection, implantation techniques, device weaning and escalation, closure strategies, anticoagulation regimens, complications, future directions and upcoming trials.

Keywords: Impella; cardiogenic shock; high-risk percutaneous coronary intervention; mechanical circulatory support.

PubMed Disclaimer

Conflict of interest statement

Disclosure: TS is a consultant for Abiomed. AK receives speaker honoraria, consultant fees and research funding from Abiomed, Abbott, CSI and Terumo. All other authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Impella Position
Figure 2:
Figure 2:. Automated Impella Controller
See this image and copyright information in PMC

References

    1. Strom J, Zhao Y, Shen C et al. Hospital variation in the utilization of short-term non-durable mechanical circulatory support in myocardial infarction complicated by cardiogenic shock. Cric Cardiovasc Interv. 2019;12:e007270. doi: 10.1161/CIRCINTERVENTIONS.118.007270. - DOI - PMC - PubMed
    1. Shah M, Patnaik S, Patel B et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol. 2018;107:287–303. doi: 10.1007/s00392-017-1182-2. - DOI - PubMed
    1. Dhruva SS, Ross JS, Mortazavi BJ et al. Use of mechanical circulatory support devices among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA Netw Open. 2021;4:e2037748. doi: 10.1001/jamanetworkopen.2020.37748. - DOI - PMC - PubMed
    1. Amin AP, Spertus JA, Curtis JP et al. The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation. 2020;141:273–84. doi: 10.1161/CIRCULATIONAHA.119.044007. - DOI - PubMed
    1. Thiele H, Zeymer U, Thelemann N et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial. Circulation. 2019;139:395–403. doi: 10.1161/CIRCULATIONAHA.118.038201. - DOI - PubMed